Staphylococcus aureus is the most infectious
Staphylococcus species and the most common bacterium isolated from hospital-acquired infections (
1). It is also the second most prevalent pathogen among patients in outpatient clinics.
S. aureus can cause mild to severe infections such as skin and soft tissue infections (SSTIs) and sepsis (
1). Additionally, it may lead to toxin-mediated infections that are associated with high mortality. Within a decade of discovery of penicillin, about 90% of the
S. aureus strains isolated from hospitals became resistant to penicillin by producing beta-lactamases. Hospital-acquired methicillin-resistant
Staphylococcus aureus (HA-MRSA) includes the strains that are resistant to all b-lactams including penicillins and cephalosporins and are isolated in healthcare environments (
2). MSRA rates increased steadily until the late 1990s when it experienced a sharp increase in rate (
2). This was followed by the appearance of community-acquired methicillin-resistant
Staphylococcus aureus (CA-MRSA) when community-acquired infections were identified with MRSA in healthy people with limited or no exposure to predisposing factors of MRSA (
1). The
mecA gene is responsible for methicillin resistance, which is carried by cassette chromosome
mec (SCCmec) (
3).
Life-threatening infections are predominantly associated with CA-MRSA that are more virulent due to carrying Panton–Valentine Leukocidin (PVL). PVL had been found mainly within CA-MSSA infections even before the emergence of MRSA. It is encoded by genes lukS-PV and lukF-PV that comprise two subunits that form pores in the cell wall of leukocytes by producing a substance called leucocidin (
4).
In Iran, the prevalence of MRSA in healthcare workers was 16% - 35% (
5,
6). The MRSA rate was 10.1% among healthcare workers from Jordan (
7), 73% among healthcare workers from Saudi Arabia (
8), and 22.5% in healthcare workers from Iraq (
9). The prevalence of MRSA carriage was also studied in Iraq. The prevalence of MRSA was found to be 4.2% (
10). In another study that was performed in urban and rural schools, the overall nasal carriage rates of
S. aureus and MRSA isolates were 17.75% and 10%, respectively (
11). MRSA infections are spreading steadily at hospitals and communities, making a public health problem. In order to control MRSA-related infections, the continuous monitoring of the prevalence of
S. aureus is needed (
1). Continuous study and monitoring of MRSA are critical for the prevention and treatment of MRSA-related infections (
12). Such studies can provide information on the spread of the bacterium, the trends of infections and the appearance of new strains in hospitals and communities, the antibiogram and antibiotic sensitivity patterns, and the risk factors associated with infection (
12). Such surveillance helps healthcare providers to plan prevention strategies and clinicians to provide accurate empiric antibiotics for infections circulating in their regions with a subsequent improvement of infection treatment outcomes (
1).